1. Home
  2. MCBS vs INMD Comparison

MCBS vs INMD Comparison

Compare MCBS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

N/A

Current Price

$34.72

Market Cap

816.1M

Sector

Finance

ML Signal

N/A

Logo InMode Ltd.

INMD

InMode Ltd.

N/A

Current Price

$13.60

Market Cap

842.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MCBS
INMD
Founded
2006
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
816.1M
842.0M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
MCBS
INMD
Price
$34.72
$13.60
Analyst Decision
Hold
Hold
Analyst Count
1
5
Target Price
$33.00
$17.33
AVG Volume (30 Days)
64.9K
820.8K
Earning Date
04-24-2026
05-06-2026
Dividend Yield
3.63%
N/A
EPS Growth
4.76
N/A
EPS
0.77
N/A
Revenue
N/A
N/A
Revenue This Year
$36.78
$1.74
Revenue Next Year
$2.44
$3.26
P/E Ratio
$43.84
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$24.53
$12.72
52 Week High
$34.45
$16.74

Technical Indicators

Market Signals
Indicator
MCBS
INMD
Relative Strength Index (RSI) 68.61 43.41
Support Level $30.83 $13.27
Resistance Level N/A $13.87
Average True Range (ATR) 0.83 0.26
MACD 0.13 -0.03
Stochastic Oscillator 86.32 28.96

Price Performance

Historical Comparison
MCBS
INMD

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: